These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33021430)

  • 21. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
    Gendy R; Delprado W; Brenner P; Brooks A; Coombes G; Cozzi P; Nash P; Patel MI
    BJU Int; 2016 Apr; 117 Suppl 4():54-9. PubMed ID: 26486968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
    Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editorial comment on: detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.
    Dalbagni G
    Eur Urol; 2010 May; 57(5):849. PubMed ID: 19524355
    [No Abstract]   [Full Text] [Related]  

  • 24. Improving practice patterns in patients with newly diagnosed bladder masses treated with transurethral resection.
    Wilson J; Drach D; Zanghi J; Siegert J
    J Osteopath Med; 2022 Jan; 122(4):169-173. PubMed ID: 35073474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.
    Mastroianni R; Brassetti A; Krajewski W; Zdrojowy R; Salhi YA; Anceschi U; Bove AM; Carbone A; De Nunzio C; Fuschi A; Ferriero M; Nacchia A; Pastore AL; Tema G; Tuderti G; Gallucci M; Simone G
    Eur Urol Focus; 2021 Nov; 7(6):1324-1331. PubMed ID: 32900676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.
    Chen GF; Shi TP; Wang BJ; Wang XY; Zang Q
    J Biol Regul Homeost Agents; 2015; 29(2):465-70. PubMed ID: 26122238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
    Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of surgical checklist during transurethral resection increases detrusor muscle collection rate and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer.
    Taoka R; Tsunemori H; Matsuoka Y; Kohashiguchi K; Miura T; Tohi Y; Miyauchi Y; Kato T; Ueda N; Sugimoto M
    Int J Urol; 2021 Jul; 28(7):727-732. PubMed ID: 33742465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes.
    Graffeille V; Verhoest G; Gryn A; Kammerer-Jacquet SF; Alimi Q; Beauval JB; Beuzit L; Pradère B; Thoulouzan M; Khene ZE; Guille F; Rioux-Leclercq N; Mathieu R; Gamé X; Bensalah K; Soulié M; Roumiguié M; Peyronnet B
    Urol Int; 2022; 106(2):122-129. PubMed ID: 33626547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study.
    Elsawy AA; Harraz AM; Ghobrial FK; Abdullatef M; Ali-El-Dein B
    Urol Oncol; 2020 Dec; 38(12):935.e1-935.e8. PubMed ID: 32654947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weight of the resected specimen after transurethral resection as a new predictive variable for recurrence of non-muscle-invasive bladder tumour.
    De La Peña E; Hernández V; Blázquez C; Martin MD; Díaz FJ; Capitán C; Alemany I; Llorente C
    BJU Int; 2013 Apr; 111(4 Pt B):E196-201. PubMed ID: 23106771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection.
    Deng N; Chen JX; Chen LW; Qiu SP; Li XF; Wang DH
    Chin Med J (Engl); 2012 Oct; 125(20):3681-6. PubMed ID: 23075724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of obturator nerve block during transurethral resection of lateral bladder wall tumors on the presence of detrusor muscle in tumor specimens and recurrence of the disease.
    Erbay G; Akyol F; Karabakan M; Celebi B; Keskin E; Hirik E
    Kaohsiung J Med Sci; 2017 Feb; 33(2):86-90. PubMed ID: 28137416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic Prognostication Using Conditional Recurrence and Progression Estimates for Patients with Nonmuscle Invasive Bladder Cancer.
    Leitner CV; Ederer IA; de Martino M; Hofbauer SL; Lucca I; Mbeutcha A; Mathieu R; Haitel A; Susani M; Shariat SF; Klatte T
    J Urol; 2016 Jul; 196(1):46-51. PubMed ID: 26835832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients.
    Sörenby A; Baseckas G; Bendahl PO; Brändstedt J; Håkansson U; Nilsson S; Patschan O; Tinzl M; Wokander M; Liedberg F; Gudjonsson S
    Scand J Urol; 2019; 53(2-3):109-115. PubMed ID: 31064253
    [No Abstract]   [Full Text] [Related]  

  • 40. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
    Herr HW; Donat SM; Dalbagni G
    J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.